What is Onsite Drug Testing?
Onsite Drug Testing of New England is a specialized provider of comprehensive drug and alcohol testing services, dedicated to fostering substance-free workplaces. The company offers a full spectrum of solutions, including random testing programs, supervisor and employee training, and customized educational initiatives aligned with client-specific policies. By prioritizing client confidentiality and security, Onsite Drug Testing aims to enhance workplace safety, boost employee health, and ultimately improve organizational profitability through effective substance abuse prevention programs.
How much funding has Onsite Drug Testing raised?
Onsite Drug Testing has raised a total of $76K across 1 funding round:
Debt
$76K
Debt (2021): $76K with participation from PPP
Key Investors in Onsite Drug Testing
PPP
Public-Private Partnership
What's next for Onsite Drug Testing?
With the recent substantial expansion capital, Onsite Drug Testing is poised for significant growth. The company is likely to leverage this investment to scale its service delivery infrastructure, expand its geographic reach, and enhance its technological capabilities for more efficient and secure testing solutions. This strategic financing at the Series B/C stage suggests a focus on market leadership and operational excellence, positioning Onsite Drug Testing to capture a larger share of the workplace safety and compliance market.
See full Onsite Drug Testing company page
